Development services
Seven decades of Precision. Hundreds of Innovators.
One Goal.
FIS partners with innovative pharma and biotech companies to accelerate development timelines and simplify the path from early process development to commercial readiness. Our approach is disciplined and efficient: we eliminate all unnecessary complexity, prioritize robust and scalable chemistry, and execute with speed and precision to reduce risk and shorten time to market.
Year after year, we bring several chemical entities forward in our laboratories, translating complex molecules into reliable, reproducible APIs. Backed by our integrated processes and analytical expertise, our methods and chemistry evolve in parallel from day one—minimizing rework, strengthening data packages, and ensuring a seamless transition into manufacturing and long-term supply.
Manufacturing services
We transform complex chemistry into seamless,large-scale production.
Why Choose FIS as Your Manufacturing Partner?
FIS is built to industrialize complex chemistry with precision, by moving programs forward seamlessly through the validation process and into commercial-scale GMP manufacturing. Our execution-driven approach emphasizes early process robustness, controlled scale-up, and Right First Time delivery, upholding the momentum and minimizing risk at every stage.
With over 3,000 m³ of total reactor capacity across three strategically aligned sites in Italy, we provide the scale, flexibility, and integration you need to support evolving program needs. As our decades-long record of successful global regulatory inspections proves, FIS delivers consistent quality, efficient technology transfer, and the reliability innovators require to bring medicines on the market with confidence.
Generics business
We are global leaders in the development and manufacture of generic APIs, offering our pharmaceutical partners a solid, long term supply base for products without patent protection. Our generics business combines decades of know-how with advanced R&D capabilities, ensuring high quality, reliable, and regulatory-compliant production across multiple treatment categories.
Our Generics APIs Portfolio covers multiple treatment categories, such anxiolytics, tranquillizers (controlled substances), anticonvulsants, antibacterials, anti-inflammatory, and ophthalmics, among others. Combining robust production capabilities with a commitment to excellence, FIS stands as a trusted partner in the global generics market, delivering reliability, quality, and innovation to the pharmaceutical industry in over 60 countries.